Moderna Covid vaccine in India: The Centre announced the formal launch of the Moderna Covid-19 vaccine in India on Tuesday, as the fourth medication in its arsenal to combat the fatal infectious illness, and stated that the Pfizer vaccine is now the priority.
“Moderna, the first globally produced vaccine, has received new drug approval. This new medicine approval is for limited usage only “In a news conference, VK Paul, a member of the NITI Aayog’s health committee, stated. Moderna will be given in two doses, according to Paul.
After AstraZeneca’s Covishield, Bharat Biotech’s Covaxin, and Russia’s Gamaleya Institute’s Sputnik V, Moderna’s injection is India’s fourth vaccination. Officials said the government will soon make room for Pfizer’s vaccine.
“Covaxin, Covishield, SputnikV, and Moderna are the four Covid-19 vaccinations now available. We’ll also conclude the transaction with Pfizer soon “On Tuesday, Paul stated.
Cipla Ltd, a Mumbai-based pharmaceutical firm, obtained clearance from India’s medicines regulator on Tuesday to import the Covid-19 vaccine produced by Moderna Inc for limited emergency use.
Cipla had applied to the Drugs Controller General of India to import the vaccine on June 28.
Despite supply shortages and worries of a third pandemic wave, India has increased its efforts to vaccinate the country’s 940 million adults, following a daily peak of 400,000 cases in May.
India has provided 323.9 million doses of Covid-19 vaccine, the most in the world.
In May, India abandoned local trials for “well-established” imported coronavirus vaccines in order to speed up its immunisation rollout in the face of a fatal second coronavirus wave.
Earlier in the day, Johnson & Johnson said that it was in negotiations with the Indian government to see how it might speed up the distribution of its single-shot Covid-19 vaccine.
After China and the United States, India has provided 323.9 million doses, the most in the world. Officials from the health ministry stated on Tuesday that the first dosage of Covid-19 vaccine was administered to an estimated 13.8 crore individuals, or 49% of the population, aged 60 and up.
The first dosage of the vaccine has been administered to about 59.7 crore persons aged 18 to 44 years, or 15% of the population, according to the report.
Several vaccine manufacturers, including Pfizer, Moderna, and Johnson & Johnson, have had negotiations with the nation, but no agreement has been reached.